Tech Company Inital Public Offerings
Immune Design IPO
On 7/24/2014, Immune Design went public.
Transaction Overview
Company Name
Announced On
7/24/2014
Transaction Type
IPO
Amount
$60,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1616 Eastlake Ave. East 310
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Website
Email Address
Overview
Immune Design is a breakthrough therapeutic vaccine product development company utilizing two proprietary and integrated platform technologies.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 7/24/2014: Elevate Research venture capital transaction
Next: 7/24/2014: Tigo Energy venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs